Clinical Trial Update: AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's Disease [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and pharmacokinetics of AZD7798 after single ascending and repeat dosing in healthy subjects and patients with Cro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• AZD7798 (AZD7798)

Snippet

Sponsor: AstraZeneca | Conditions: Healthy Subjects, Crohns Disease | Phase 1 | Status: COMPLETED